Close Menu
Home › Agilent's Opdivo CDx Gets Expanded CE Mark in Europe

Agilent's Opdivo CDx Gets Expanded CE Mark in Europe

Jun 16, 2017

NEW YORK (GenomeWeb) – Agilent Technologies announced today that its Dako PD-L1 IHC 28-8 pharmDx test, a companion diagnostic for Bristol-Myers Squibb's cancer drug Opdivo (nivolumab), has has received an expanded CE mark for use in Europe.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
20
Featured Webinar

A New Multiplex Syndromic System For Respiratory Diagnosis And Improved Patient Care

Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar
21
Featured Webinar

A Long-Read vs. Short-Read Platform Comparison (Part 2): Best NGS Approaches for Human Transcriptome Sequencing

Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Featured Webinar

Advancing Agricultural Genomics with Low-Cost NGS Genotyping

Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.

Mar
27
Featured Webinar

How One NGS Core Lab Reduced Sequencing Costs with a Novel Library Normalization Kit

Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

What's Popular?

In Molecular Diagnostics

  1. Academic, Community, and Health System Hospitals Face Unique Hurdles Implementing Precision Medicine

    Premium

  2. SpeeDx Signs Distributor Deals in Middle East

  3. TGen Inks Tuberculosis Test Deal with Advanced Biological Laboratories

  4. BRCA Screening Guidelines Too Reliant on Family History, Stakeholders Tell USPSTF

    Premium

  5. First Veterans Affairs MDx Lab Launches NGS-Based Cancer Panel; Others to Follow

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.